A Business Breakfast and Roundtable on Combating Hepatitis in Africa
Caption 1: From L to R: Mr. Bassem Bibi, Abbot, Florizelle Liser, CCA, H.E. Aïssata Issoufou Mahamadou, Republic of Niger, Minister Dr. Idi Illiassou Mainassara, Niger, Amb. Jessye Lapenn, U.S. Mission to the African Union, Dr. Papa Salif Sow, Gilead Sciences Caption 2: H.E. Amira El Fadil, Commissioner for Social Affairs, African Union Commission Caption 3: From L to R: Zouera Youssoufou, Dangote Foundation moderates a fireside chat with H.E. Aïssata Issoufou Mahamadou, First Lady, Republic of Niger Caption 4: A cross section of delegates at the roundtable
On February 11, 2020, CCA hosted a ‘Business Breakfast and Roundtable on Combating Hepatitis in Africa’ on the sidelines of the 2020 African Union Summit. The roundtable convened a select group of roughly 60 high-level U.S. and African decision makers from the public and private sectors. The program included special remarks from H.E. Aïssata Issoufou Mahamadou, First Lady, Republic of Niger; H.E. Amira El Fadil, Commissioner for Social Affairs, African Union Commission; H.E. Dr. Idi Illiassou Mainassara Minister of Public Health, Niger and Amb. Jessye Lapenn, U.S. Ambassador, U.S. Mission to the African Union as well as Mr. Bassem Bibi, VP and General Manager, Infectious Disease - Africa, Rapid Diagnostics, Abbott and Dr. Papa Salif Sow, VP Program Development & Management, Access Operations & Emerging Markets, Africa/Geneva, Gilead Sciences. Government representatives from Chad, Mali, Zimbabwe, Burundi, Ethiopia and Mozambique were also in attendance.
The purpose of the roundtable was to discuss strategies aimed at achieving the AU’s political declaration to eradicate hepatitis in Africa, which was launched at this year’s AU Summit. The roundtable featured keynote remarks from H.E. El Fadil who highlighted the rising threat of viral hepatitis in the region, and the goals of the new declaration. Each year 1.4 million people die from hepatitis b and c, which has increased 22 percent since 2000. In 2016, 47 African Governments adopted the Africa Regional Framework for Hepatitis Control (2016-2020), which called for Member States to develop and implement hepatitis specific National Strategic Plan. To date, only 18 countries have formulated a national hepatitis strategic plan.
At this year’s AU Summit, Heads of State adopted the Cairo Declaration on Hepatitis Prevention, Care and Treatment in Africa. The declaration places investing in viral hepatitis elimination high on African governments agendas. It seeks to scale-up care and antiviral treatment for people with viral hepatitis as well as increase domestic funding and the number of trained health providers to prevent deaths in the medium and long-term.
The roundtable included a moderated discussion on leveraging PPPs to combat hepatitis which was moderated by Michael Ninburg, President, World Hepatitis Alliance and a fireside chat with H.E. Aïssata Issoufou Mahamadou, First Lady, Republic of Niger and Zouera Youssoufou, Managing Director and CEO, Dangote Foundation. During her remarks, H.E. Mahamadou appealed to H.E. Amira El Fadil and the private sector to mobilize resources for Africa to achieve its goal of eliminating viral hepatitis by 2030. The roundtable was sponsored by Abbot and Gilead Sciences.